Skip to main content
Clinical Trials/NCT05808257
NCT05808257CompletedNot Applicable

Superpulsed Thulium Fiber Laser VS. Pulse Modulated High Power Holmium:YAG Laser For Retrograde Intrarenal Surgery

Icahn School of Medicine at Mount Sinai2 sites in 1 country82 target enrollmentStarted: January 7, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
82
Locations
2
Primary Endpoint
Number of Participants With Stone Free Status

Study Overview

Brief Summary

This is a randomized prospective study to compare stone free rates and operative efficiency of two laser systems used during retrograde intrarenal surgery for kidney stone disease:

  1. A superpulsed thulium fiber laser (thulium)
  2. A pulse modulated high power holmium laser (Holmium)

Detailed Description

This is a randomized prospective study. The purpose is to compare the stone free rate and operative efficiency of two leading contemporary laser systems used during retrograde intrarenal surgery for kidney stone disease. The researchers will compare the following two systems:

  1. A superpulsed thulium fiber laser (thulium)
  2. A pulse modulated high power holmium laser (Holmium)

The researchers will recruit 82 subjects undergoing single stage unilateral ureteroscopy for renal stones with a volume between >5mm to < 20 mm. Subjects will be randomized to undergo lithotripsy with either Ho:YAG or Thulium lasers.

All subjects will undergo surgical interventions that abide by broadly accepted guidelines and standards of care.

The primary outcome is stone free rate evaluated by postoperative CT scans done 6-12 weeks after surgery.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Number of Participants With Stone Free Status

Time Frame: 6-12 weeks postoperative

Stone free status as determined by 6-12 week postoperative CT scan to assess laser efficacy

Secondary Outcomes

  • Fragmentation Speed(Intraoperatively (Day 1))
  • Lasing Activity(Intraoperatively (Day 1))
  • Energy Utilization(Intraoperatively (Day 1))

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Mantu Gupta

Professor of Urology

Icahn School of Medicine at Mount Sinai

Study Sites (2)

Loading locations...

Similar Trials